Down-regulation of transforming growth factor β receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity

  • Authors:
    • Hyun Jin Bae
    • Jung Woo Eun
    • Ji Heon Noh
    • Jeong Kyu Kim
    • Kwang Hwa Jung
    • Hong Jian Xie
    • Won Sang Park
    • Jung Young Lee
    • Suk Woo Nam
  • View Affiliations

  • Published online on: September 1, 2009     https://doi.org/10.3892/or_00000459
  • Pages: 475-480
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The transforming growth factor receptor III (TGFβRIII) is the most abundant and essential TGF-β binding protein that functions as a co-receptor with other receptors in TGF-β signaling. In earlier studies, expression of TGFβRIII was reported to be decreased in a variety of human cancers. Functional assessment of TGFβRIII was performed in many previously studied cancers but not in hepatocellular carcinoma. Therefore, in this study, we investigated the expression and genetic alterations of TGFβRIII in hepatocellular carcinoma (HCC) by quantitative real-time PCR (qRT-PCR) and single-strand conformation polymorphism (SSCP) analysis. The qRT-PCR showed down-regulation of TGFβRIII in the tumor samples. To investigate whether genetic alterations mediated decreased expression of TGFβRIII, we performed mutation analysis of 67 human HCC tissues by SSCP and direct sequencing. We found five previously reported and one novel single nucleotide polymorphisms in exons 2, 3, 5, 13 and 14, but no mutations were detected. These polymorphisms were not associated with amino acid changes except for a base change found in exon 2 (TCC↷TTC, S15F). The loss of heterozygosity (LOH) analysis performed on 10 tumors and corresponding normal pairs, showed a low rate of LOH (2/10). The results of this study suggest that TGFβRIII is transcriptionally down-regulated in hepatocellular carcinoma. In addition, genetic alterations did not appear to be associated with the reduced expression level of TGFβRIII. To clarify the role of TGFβRIII in hepatocellular tumor development and progression, functional analysis is needed in future studies.

Related Articles

Journal Cover

September 2009
Volume 22 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Bae HJ, Eun JW, Noh JH, Kim JK, Jung KH, Xie HJ, Park WS, Lee JY and Nam SW: Down-regulation of transforming growth factor β receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity. Oncol Rep 22: 475-480, 2009
APA
Bae, H.J., Eun, J.W., Noh, J.H., Kim, J.K., Jung, K.H., Xie, H.J. ... Nam, S.W. (2009). Down-regulation of transforming growth factor β receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity. Oncology Reports, 22, 475-480. https://doi.org/10.3892/or_00000459
MLA
Bae, H. J., Eun, J. W., Noh, J. H., Kim, J. K., Jung, K. H., Xie, H. J., Park, W. S., Lee, J. Y., Nam, S. W."Down-regulation of transforming growth factor β receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity". Oncology Reports 22.3 (2009): 475-480.
Chicago
Bae, H. J., Eun, J. W., Noh, J. H., Kim, J. K., Jung, K. H., Xie, H. J., Park, W. S., Lee, J. Y., Nam, S. W."Down-regulation of transforming growth factor β receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity". Oncology Reports 22, no. 3 (2009): 475-480. https://doi.org/10.3892/or_00000459